CPT1A and acute myeloid leukemia: demonstrated that inhibition of CPT-1A results in enhanced sensitivity to cytotoxic agents in AML cells, probably based on the role of FAO in controlling mitochondrial permeability dependent on B-cell lymphoma 2 antagonist/killer (BAK) (74).